Hewlett-Packard reported quarterly earnings that beat analysts’ expectations but the company’s revenue and outlook fell short as the company grapples with weak PC and printer sales.
Regards,
Don
Hewlett-Packard reported quarterly earnings that beat analysts’ expectations but the company’s revenue and outlook fell short as the company grapples with weak PC and printer sales.
Regards,
Don
Australian shares could open lower after weak data on European business activity renewed concerns about a recession in the euro zone and the implications for the global economy.
Regards,
Don
T-Mobile USA, which just had its acquisition by AT&T blocked by regulators, is now urging the federal government to block another deal in the wireless world: Verizon’s planned purchase spectrum from cable companies for $3.6 billion.
Regards,
Don
Nokia will next week unveil a new, cheaper smartphone using Microsoft’s Windows Phone software, targeting a wider market for its new range of smartphones, two sources close to the company said.
Cheaper phones are the key for Nokia and Microsoft in their battle to win a larger share of the market, analysts say.
Regards,
Don
Fitch ratings agency on Wednesday slashed its rating for Greek sovereign debt to “C” from “CCC,” indicating that default is “highly likely in the near term.”
Regards,
Don
Industry Analysis:
The Dow Chemical Company (NYSE:DOW) is ranked 3rd among its 151 competitors by dividend yield of 2.90 percent. The company is ranked 15th among its industry peers by long term growth rate. The company maintains the long term growth rate of 9.97 percent as compared to highest long term growth rate of 44 percent in its industry.
Regards,
Don
Introduction:
BioPharm Asia Inc (PINK:BFAR) is engaged in marketing and sale of medical products to drug stores, hospitals, neighborhood clinics and other medicine retail outlets. Based in Tonghua County, China the company has wide range of products including 300 prescription drugs and more than 1,150 over the counter drugs comprising of western medicines and traditional Chinese medicines. The company has more than 85 nutritional supplements in its product line which consists of healthcare supplements, vitamins, minerals, dietary products and several herbal remedies. The company has reported to have 360 retail drug stores as on December 31st, 2009.
Regards,
Don
Introduction:
Baxter International Inc (NYSE:BAX)Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is generally conducted in a hospital or clinic. The company serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. Baxter International Inc. sells its products through its direct sales force and also to and through independent distributors, drug wholesalers acting as sales agents, and specialty pharmacy or homecare companies. The company was founded in 1931 and is based in Deerfield, Illinois.
Regards,
Don
Daily Stock News:
Coates International Ltd (OTC:COTE) penny stock last close at $0.139 with traded volume of 38,417 shares as compared to its average traded volume of 118,822 shares per day. The company’s (penny stock) total outstanding common stock accumulates up to 300.25 million shares out of which only 38.18 million shares are floated in the stock market.
It seems that the share (penny stock) price movement depicts stability as per its beta value of 0.67 times which means that the share (penny stock) price is likely to change by 0.67 times against one point change in market index.
Looking at its price history the share (penny stock) price traded between the prices ranges of $0.12 to $0.75 in last one year. This can be derived that the share price is likely to find support at $0.12 while resistance could be seen at $0.75 level.
(Read the Rest of the Article…)
Regards,
Don
Introduction:
Walter Energy Inc (NYSE:WLT) was incorporated in 1946 and is engaged in production and export of metallurgical coal for the steel industry in United States. Based in Birmingham, Alabama, the company is also involved in production of steam coal, coal bed methane gas, metallurgical coke and other related products. The company caters the need of electric utility and industrial customers. The company was initially registered under the name of Walter Industries Inc and later in April, 2009 changed its name to Walter Energy Inc.
Regards,
Don
Daily Stock News:
View Systems Inc (OTC:VSYM) penny stock dropped 4.76 percent to $0.020 in its last trading session. Its traded volume stood at 369,222 shares while on average it maintains the volume of 211,752 shares per day. The company’s (penny stock) total outstanding common stock accumulates up to 133.18 million shares out of which 80.73 million shares are floated in the stock market.
Looking at its price history the share (penny stock) price traded between the prices ranges of $0.00 to 40.03 in last 52 weeks. Its support and resistance levels can also be derived from its price history which would stand at $0.00 and $40.03 respectively.
The share (penny stock) price is negatively correlated with market index as per its beta value of 0.24. This means that the share(penny stock) price is likely to move by 0.24 times against one point change in market index in opposite direction.
(Read the Rest of the Article…)
Regards,
Don
powered by RSS Just Better

